Sig North Trading, Ulc Bausch Health Companies Inc. Put Options Transaction History

Sig North Trading, Ulc

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 07, 2024	BUY	$7.77 - $10.61 $799,533 - $1.09 Million	102,900 Added 166.5%	164,700 $1.75 Million
Q3 2023 Nov 14, 2023	SELL	$7.69 - $9.71 $207,630 - $262,170	-27,000 Reduced 30.41%	61,800 $507,000
Q2 2023 Aug 11, 2023	SELL	$5.72 - $8.8 $1.18 Million - $1.82 Million	-206,600 Reduced 69.94%	88,800 $710,000
Q1 2023 May 16, 2023	SELL	$6.28 - $9.85 $448,392 - $703,290	-71,400 Reduced 19.47%	295,400 $2.39 Million
Q4 2022 Feb 14, 2023	SELL	$6.09 - $7.93 $482,328 - $628,056	-79,200 Reduced 17.76%	366,800 $2.3 Million

Q3 2022 Nov 14, 2022	BUY	$4.58 - $9.21 $1.56 Million - $3.14 Million	340,500 Added 322.75%	446,000 $3.1 Million
Q2 2022 Aug 15, 2022	SELL	$7.06 - $23.63 $160,968 - $538,764	-22,800 Reduced 17.77%	105,500 $883,000
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $3.58 Million - $4.61 Million	-165,900 Reduced 56.39%	128,300 $2.97 Million
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $6.77 Million - $8.53 Million	294,200 New	294,200 $8.09 Million

282

278M

21.5M

21.8M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.62B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Sig North Trading, Ulc, based on Form 13F filings with the SEC.

Stay updated on Sig North Trading, Ulc with notifications on news.